Breitkreutz, I., Kosely, F., Heining, C., Hillengaß, J., Egerer, G., Ho, A. D., . . . Raab, M. (2016). Dose-intensified bendamustine followed by autologous peripheral blood stem cell support in relapsed and refractory multiple myeloma with impaired bone marrow function. Hematological oncology, 34(4), . https://doi.org/10.1002/hon.2199
Chicago-Zitierstil (17. Ausg.)Breitkreutz, Iris, Florentina Kosely, Christoph Heining, Jens Hillengaß, Gerlinde Egerer, Anthony Dick Ho, Hartmut Goldschmidt, und Marc-Steffen Raab. "Dose-intensified Bendamustine Followed by Autologous Peripheral Blood Stem Cell Support in Relapsed and Refractory Multiple Myeloma with Impaired Bone Marrow Function." Hematological Oncology 34, no. 4 (2016). https://doi.org/10.1002/hon.2199.
MLA-Zitierstil (9. Ausg.)Breitkreutz, Iris, et al. "Dose-intensified Bendamustine Followed by Autologous Peripheral Blood Stem Cell Support in Relapsed and Refractory Multiple Myeloma with Impaired Bone Marrow Function." Hematological Oncology, vol. 34, no. 4, 2016, https://doi.org/10.1002/hon.2199.